Is sirolimus better than paclitaxel? A review of the comparative data on drug-eluting stents

Simon J. Corbett, Rade Babic, John Cosgrave, Giuseppe M. Sangiorgi, Antonio Colombo

Research output: Contribution to journalArticlepeer-review

Abstract

Drug-eluting stents have been unequivocally demonstrated to reduce in-stent restenosis when compared to bare metal stents, with resultant lower rates of repeat revascularization. Comparative data are now emerging which compare the performance of sirolimus- and paclitaxel-eluting stents to each other rather than to bare metal stents. In this article, we review these data with the aim of placing the studies in context thereby providing an overall view of this rapidly developing field as it stands at present.

Original languageEnglish
Pages (from-to)159-164
Number of pages6
JournalCardiovascular Revascularization Medicine
Volume7
Issue number3
DOIs
Publication statusPublished - Jul 2006

Keywords

  • Paclitaxel
  • Percutaneous coronary intervention
  • Sirolimus
  • Stent

ASJC Scopus subject areas

  • Molecular Medicine
  • Cardiology and Cardiovascular Medicine
  • Surgery

Fingerprint Dive into the research topics of 'Is sirolimus better than paclitaxel? A review of the comparative data on drug-eluting stents'. Together they form a unique fingerprint.

Cite this